In the article by Anderson et al, “ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction),” which appeared in the August 14, 2007, online issue of the journal (Circulation. 2007;116:e148–e304), the following corrections are necessary:
On multiple pages: Replace “calcium antagonist(s)” with “calcium channel blocker(s)” at all occurrences. These are as follows:
page e183: Class IIa Recommendation 4; Class IIb Recommendations 1 and 2;
page e190: title of Table 16;
page e240: first column of Table 22;
page e260: Class I Recommendations 1, 2, and 3; Class IIa Recommendation 2;
page e261: Class IIb Recommendation; left column, first paragraph under “6.6.1. Coronary Artery Spasm With Cocaine Use”; right column, line 6;
page e262: left column, second paragraph;
page e263: right column, last paragraph;
page e264: left column, first paragraph; and
page e265: right column, last paragraph.
On page e185, Table 13: In the first sentence of the footnote, add “of UFH” after “50 to 60 U per kg.”
On page e193, Figure 7 caption: Delete “B” from first sentence so that parenthetical wording is “e.g., Boxes B1 and B2.”
In Table 18, page e215:
For the PURSUIT row: The GP IIb/IIIa n should be 670/4722; the GP IIb/IIIa percentage should be 14.2*; the ARR percentage should be 1.5; the RR should be 0.90; the 95% CI should be 0.82 to 1.00; and the p should be 0.04.
For the ISAR-REACT (ACS) row: The 95% CI should be 0.57 to 0.97.
For the All ACS trials row: The GP IIb/IIIa n should be 1726/16 668; the GP IIb/IIIa percentage should be 10.4; the ARR percentage should be 1.3; the RR should be 0.86; and the 95% CI should be 0.81 to 0.93.
For the All PCI trials and ACS trials row: The GP IIb/IIIa n should be 2134/24 274; the GP IIb/IIIa percentage should be 8.8; the ARR percentage should be 1.7; the RR should be 0.83; and the 95% CI should be 0.83 to 0.84.
On page e241, right column, second paragraph, line 4: Change “nonrandomized” to “randomized” so that sentence reads “In contrast, a meta-analysis of randomized trials of early (less than 14d) initiation … ”
These changes have been made to the current online version of the article.